Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA SUVEN LIFE SCIENCES TORRENT PHARMA/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 58.9 -20.5 - View Chart
P/BV x 14.2 5.8 245.2% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 TORRENT PHARMA   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-23
SUVEN LIFE SCIENCES
Mar-23
TORRENT PHARMA/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,72394 1,837.4%   
Low Rs1,24345 2,760.5%   
Sales per share (Unadj.) Rs284.20.6 45,782.2%  
Earnings per share (Unadj.) Rs36.8-5.4 -678.4%  
Cash flow per share (Unadj.) Rs57.7-5.1 -1,125.6%  
Dividends per share (Unadj.) Rs22.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs183.117.2 1,064.0%  
Shares outstanding (eoy) m338.45218.07 155.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.2111.8 4.7%   
Avg P/E ratio x40.3-12.8 -315.0%  
P/CF ratio (eoy) x25.7-13.5 -189.8%  
Price / Book Value ratio x8.14.0 200.8%  
Dividend payout %59.80-   
Avg Mkt Cap Rs m501,77915,131 3,316.2%   
No. of employees `000NANA-   
Total wages/salary Rs m16,777186 9,009.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m96,202135 71,055.1%  
Other income Rs m63284 748.3%   
Total revenues Rs m96,834220 44,039.3%   
Gross profit Rs m28,240-1,196 -2,360.5%  
Depreciation Rs m7,06665 10,799.2%   
Interest Rs m3,3345 61,977.7%   
Profit before tax Rs m18,472-1,183 -1,561.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,0190-   
Profit after tax Rs m12,452-1,183 -1,052.9%  
Gross profit margin %29.4-883.6 -3.3%  
Effective tax rate %32.60-   
Net profit margin %12.9-873.5 -1.5%  
BALANCE SHEET DATA
Current assets Rs m53,1373,455 1,538.1%   
Current liabilities Rs m54,4731,050 5,186.6%   
Net working cap to sales %-1.41,776.0 -0.1%  
Current ratio x1.03.3 29.7%  
Inventory Days Days153,948 0.4%  
Debtors Days Days7218 3.4%  
Net fixed assets Rs m91,3901,373 6,655.1%   
Share capital Rs m1,692218 776.0%   
"Free" reserves Rs m60,2883,535 1,705.4%   
Net worth Rs m61,9813,753 1,651.4%   
Long term debt Rs m24,9620-   
Total assets Rs m144,6824,828 2,996.7%  
Interest coverage x6.5-218.8 -3.0%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.70 2,371.1%   
Return on assets %10.9-24.4 -44.7%  
Return on equity %20.1-31.5 -63.8%  
Return on capital %25.1-31.4 -80.0%  
Exports to sales %21.840.4 54.0%   
Imports to sales %0839.8 0.0%   
Exports (fob) Rs m20,99455 38,345.6%   
Imports (cif) Rs mNA1,137 0.0%   
Fx inflow Rs m20,99455 38,345.6%   
Fx outflow Rs m3,7351,137 328.5%   
Net fx Rs m17,259-1,082 -1,594.7%   
CASH FLOW
From Operations Rs m23,681-1,031 -2,295.9%  
From Investments Rs m-24,153-2,606 926.7%  
From Financial Activity Rs m7743,955 19.6%  
Net Cashflow Rs m1,101317 346.9%  

Share Holding

Indian Promoters % 71.3 69.6 102.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 21.3 0.6 3,872.7%  
FIIs % 14.1 0.5 2,607.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 28.8 30.4 94.5%  
Shareholders   69,117 74,003 93.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Torrent Pharma vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Torrent Pharma vs Suven Life Sciences Share Price Performance

Period Torrent Pharma Suven Life Sciences S&P BSE HEALTHCARE
1-Day 1.45% 0.30% 1.18%
1-Month -0.30% -2.06% -0.75%
1-Year 68.52% 114.92% 61.82%
3-Year CAGR 27.16% 14.94% 18.16%
5-Year CAGR 21.87% -16.22% 19.79%

* Compound Annual Growth Rate

Here are more details on the Torrent Pharma share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of Torrent Pharma hold a 71.3% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Torrent Pharma and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, Torrent Pharma paid a dividend of Rs 22.0 per share. This amounted to a Dividend Payout ratio of 59.8%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Torrent Pharma, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.